Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2012, Article ID 147863, 9 pages
http://dx.doi.org/10.1155/2012/147863
Research Article

Topical Curcumin-Based Cream Is Equivalent to Dietary Curcumin in a Skin Cancer Model

1Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA
2Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA
3Department of Biochemistry, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA
4Department of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA
5Boudreaux’s Compounding Pharmacy, Shreveport, LA 71130-3932, USA
6Department of Surgery, Overton Brooks VA Medical Center, Shreveport, LA 71130-3932, USA

Received 7 September 2012; Accepted 20 November 2012

Academic Editor: Ajit K. Verma

Copyright © 2012 Kunal Sonavane et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Alam and D. Ratner, “Cutaneous squamous-cell carcinoma,” The New England Journal of Medicine, vol. 344, no. 13, pp. 975–983, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. C. L. Green and P. A. Khavari, “Targets for molecular therapy of skin cancer,” Seminars in Cancer Biology, vol. 14, no. 1, pp. 63–69, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. E. Rowe, R. J. Carroll, and C. L. Day, “Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection,” Journal of the American Academy of Dermatology, vol. 26, no. 6, pp. 976–990, 1992. View at Google Scholar · View at Scopus
  4. V. de Lima Vazquez, T. Sachetto, N. M. Perpetuo, and A. L. Carvalho, “Prognostic factors for lymph node metastasis from advanced squamous cell carcinoma of the skin of the trunk and extremities,” World Journal of Surgical Oncology, vol. 6, article 73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. G. Joseph, W. P. Zulueta, and P. J. Kennedy, “Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome,” Australian and New Zealand Journal of Surgery, vol. 62, no. 9, pp. 697–701, 1992. View at Google Scholar · View at Scopus
  6. R. E. Kwa, K. Campana, and R. L. Moy, “Biology of cutaneous squamous cell carcinoma,” Journal of the American Academy of Dermatology, vol. 26, no. 1, pp. 1–26, 1992. View at Google Scholar · View at Scopus
  7. D. H. Kraus, J. F. Carew, and L. B. Horrison, “Regional lymph node metastasis from cutaneous squamous cell carcinoma,” Archives of Otolaryngology—Head and Neck Surgery, vol. 124, no. 5, pp. 582–587, 1998. View at Google Scholar · View at Scopus
  8. R. Kuttan, P. C. Sudheeran, and C. D. Josph, “Turmeric and curcumin as topical agents in cancer therapy,” Tumori, vol. 73, no. 1, pp. 29–31, 1987. View at Google Scholar · View at Scopus
  9. C. H. Hsu and A. L. Cheng, “Clinical studies with curcumin,” Advances in Experimental Medicine and Biology, vol. 595, pp. 471–480, 2007. View at Google Scholar
  10. J. Dujic, S. Kippenberger, A. Ramirez-Bosca et al., “Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model,” International Journal of Cancer, vol. 124, no. 6, pp. 1422–1428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Phillips, C. Clark, L. Herman-Ferdinandez et al., “Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo,” Otolaryngology—Head and Neck Surgery, vol. 145, pp. 58–63, 2011. View at Google Scholar
  12. W. F. Hua, Y. S. Fu, Y. J. Liao et al., “Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells,” European Journal of Pharmacology, vol. 637, no. 1–3, pp. 16–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. S. Vourlekis and E. Szabo, “Predicting success in cancer prevention trials,” Journal of the National Cancer Institute, vol. 95, no. 3, pp. 178–179, 2003. View at Google Scholar · View at Scopus
  14. J. L. Clifford, X. Yang, E. Walch, M. Wang, and S. M. Lippman, “Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells,” Molecular Cancer Therapeutics, vol. 2, pp. 453–459, 2003. View at Google Scholar
  15. C. A. O. Nathan, N. Amirghahari, F. Abreo et al., “Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway,” Clinical Cancer Research, vol. 10, no. 17, pp. 5820–5827, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Kleiner-Hancock, R. Shi, A. Remeika et al., “Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts,” BMC Cancer, vol. 10, article 394, 2010. View at Google Scholar
  17. Z. Syed, S. B. Cheepala, J. N. Gill et al., “All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis,” Cancer Prevention Research, vol. 2, no. 10, pp. 903–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Clark, M. D. McEachern, S. H. Shah et al., “Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma,” Cancer Prevention Research, vol. 3, no. 12, pp. 1586–1595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Yin, S. Cheepala, J. N. Roberts, K. Syson-Chan, J. DiGiovanni, and J. L. Clifford, “Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions,” Molecular Cancer, vol. 5, article 15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Wheeler, E. F. Dunn, and P. M. Harari, “Understanding resistance to EGFR inhibitors-impact on future treatment strategies,” Nature Reviews Clinical Oncology, vol. 7, no. 9, pp. 493–507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Claerhout, L. Verschooten, S. Van Kelst et al., “Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma,” International Journal of Cancer, vol. 127, no. 12, pp. 2790–2803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. W. E. Pierceall, L. H. Goldberg, M. A. Tainsky, T. Mukhopadhyay, and H. N. Ananthaswamy, “ras Gene mutation and amplification in human nonmelanoma skin cancers,” Molecular Carcinogenesis, vol. 4, no. 3, pp. 196–202, 1991. View at Google Scholar · View at Scopus
  23. X. Zhang, T. Makino, F. C. Muchemwa et al., “Activation of the extracellular signal-regulated kinases signaling pathway in squamous cell carcinoma of the skin,” Bioscience Trends, vol. 1, no. 3, pp. 156–160, 2007. View at Google Scholar · View at Scopus
  24. J. Albanell, J. Codony-Servat, F. Rojo et al., “Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor α expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments,” Cancer Research, vol. 61, no. 17, pp. 6500–6510, 2001. View at Google Scholar · View at Scopus
  25. S. Rose-John, J. Scheller, G. Elson, and S. A. Jones, “Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer,” Journal of Leukocyte Biology, vol. 80, no. 2, pp. 227–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Benoy, R. Salgado, C. Colpaert, R. Weytjens, P. B. Vermeulen, and L. Y. Dirix, “Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients,” Clinical Breast Cancer, vol. 2, no. 4, pp. 311–315, 2002. View at Google Scholar · View at Scopus
  27. A. N. Cohen, M. S. Veena, E. S. Srivatsan, and M. B. Wang, “Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Iκβ kinase,” Archives of Otolaryngology—Head and Neck Surgery, vol. 135, no. 2, pp. 190–197, 2009. View at Publisher · View at Google Scholar · View at Scopus